Hotline:
+ 49 (0) 2204 2918806

Estudios en la categoría Medicamentos/Fármacos

Artículo 1 hasta 10 de 7745

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 775
  1. Precio neto*
    Año
  2. US$ 1.894,08
    2012
    Für diese Studie liegt keine Bewertung vor.

    Myasthenia Gravis – Pipeline Review, H2 2012

    Global Markets Direct
    59 Páginas
    Introduction Global Markets Direct’s, 'Myasthenia Gravis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Myasthenia Gravis, complete with latest updates, and special features on late-stage and discontinued projects. It also
    Englisch | Report | Código: 317911
  3. US$ 2.367,60
    2014
    Für diese Studie liegt keine Bewertung vor.

    Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014

    GlobalData
    192 Páginas
    GlobalData's clinical trial report, “Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2014" provides data on the Post Menopausal Osteoporosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Post Menopausal Osteoporosis. It includes an overview of the trial nu
    Englisch | Zukunftsanalyse | Código: 403139
  4. US$ 284,11
    2015
    Für diese Studie liegt keine Bewertung vor.

    Prana Biotechnology Limited (PBT) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of Prana Biotechnology Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The
    Englisch | Zukunftsanalyse | Código: 85159
  5. US$ 1.420,56
    2014
    Für diese Studie liegt keine Bewertung vor.

    LiPlasome Pharma ApS - Product Pipeline Review - 2014

    Global Markets Direct
    28 Páginas
    Global Markets Direct’s, ‘LiPlasome Pharma ApS - Product Pipeline Review - 2014’, provides an overview of the LiPlasome Pharma ApS’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of LiPlasome Pharma ApS’s, complete with comparative a
    Englisch | Zukunftsanalyse | Código: 404039
  6. US$ 2.367,60
    2012
    Für diese Studie liegt keine Bewertung vor.

    Turkey Dental Devices Investment Opportunities, Analysis and Forecasts to 2018

    Global Markets Direct
    129 Páginas
    Introduction Global Markets Direct’s new report, “Turkey Dental Devices Investment Opportunities, Analysis and Forecasts to 2018” provides key market data on the Turkey Dental Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories
    Englisch | Report | Código: 318551
  7. US$ 3.783,42
    2014
    Für diese Studie liegt keine Bewertung vor.

    EpiCast Report: Graft-Versus-Host Disease - Epidemiology Forecast to 2023

    GlobalData
    56 Páginas
    Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either acute GVHD (aGVHD) or chronic GVHD (cGVHD). Both aGVHD and cGVHD comm
    Englisch | Zukunftsanalyse | Código: 403481
  8. US$ 284,11
    2015
    Für diese Studie liegt keine Bewertung vor.

    Formosa Laboratories, Inc. (4746) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Páginas
    Formosa Laboratories, Inc. (Formosa) is a pharmaceutical company. The company develops and markets active pharmaceutical ingredients and UV filters. It offers active pharmaceutical ingredients, such as anticancers, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators
    Englisch | Zukunftsanalyse | Código: 338920
  9. US$ 236,76
    2014
    Für diese Studie liegt keine Bewertung vor.

    Binex Co., Ltd. (053030) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    20 Pages
    Binex Co., Ltd. (Binex) is a pharmaceutical company. It undertakes the manufacturing and distribution of biologic and pharmaceutical products. The company holds expertise in the biotechnology field, and provides outsourcing solutions to Korea’s biotechnology sector. Binex’s product portfolio includes bisroot products; digestive produc
    Englisch | Zukunftsanalyse | Código: 159785
  10. US$ 1.420,56
    2013
    Für diese Studie liegt keine Bewertung vor.

    Edgemont Pharmaceuticals, LLC - Product Pipeline Review - 2013

    Global Markets Direct
    18 Páginas
    Global Market Direct’s pharmaceuticals report, “Edgemont Pharmaceuticals, LLC - Product Pipeline Review - 2013” provides data on the Edgemont Pharmaceuticals, LLC’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorma
    Englisch | Zukunftsanalyse | Código: 386519
  11. US$ 2.367,60
    2014
    Für diese Studie liegt keine Bewertung vor.

    Tracheobronchitis Global Clinical Trials Review, H2, 2014

    GlobalData
    97 Páginas
    GlobalData's clinical trial report, “Tracheobronchitis Global Clinical Trials Review, H2, 2014" provides data on the Tracheobronchitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tracheobronchitis. It includes an overview of the trial numbers and their recruitment statu
    Englisch | Zukunftsanalyse | Código: 987672195

Artículo 1 hasta 10 de 7745

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 775